Why Seers and InBody Fell: A Q3 Loss, and a 27% Drop After a Beat
Seers fell 29.95% after a confirmed Q3 loss. InBody fell 27.23% a day after an earnings beat, and no filing today explains it.

Seoul — Seers closed down 29.95% today. InBody closed down 27.23%. Seers has a confirmed cause: a Q3 swing to an operating loss, shown in a filing and in press reports. InBody posted results reported as strong a day earlier, and no filing shows a direct reason for today's fall.
Paper Trail's own check log shows both stocks were picked from the biggest closing decliners today. We make no buy call.
The whole market was weak. KOSPI fell 6.02% to 5,059.69 and KOSDAQ fell 5.03% to 644.27. In the U.S. on Nov 5, the S&P 500 lost 4.36% and the Nasdaq Composite lost 5.52%. Both stocks still fell far more than the indexes, so the market alone does not explain them.
At a glance
| Stock | Why it fell | Verdict | Basis | What to check next |
|---|---|---|---|---|
| Seers | Q3 operating loss. Reports cite a server supply shortfall for its main product | Company problem confirmed | Filing confirmed (preliminary earnings); details from press | Q4 results, filings on the 2nd convertible bond |
| InBody | Down 27% a day after an earnings beat. No filing today | Reason not confirmed | None | Treasury-share disposal filing, flows after the short-selling restriction |
Seers fell 29.95% as Q3 turned to a loss

Seers closed at 14,500 won. That is 48.2% below its three-month high close of 28,000 won on Oct 26. It is down 34.7% over five days and 41.4% since Aug 10. DART shows a preliminary consolidated operating results disclosure posted at 7:40 a.m. today. The title carries no figures, so the numbers and the cause come from press reports.
Those reports put the Q3 operating loss at 1.899 billion won. Revenue fell 38%. Sales of its main product, Think, dropped 70%. Several outlets named a server supply shortfall and delivery delays as the cause.
Some facts cut the other way. The Stock reported cumulative operating profit of 24.9 billion won for the first three quarters. The quarter is a loss, but the nine-month figure is a profit. Electronic Times reported the company is focusing on a Q4 recovery. That is the company's own account, not a confirmed recovery. There is also a burden in the last 30 days of filings: the decision to issue the 2nd convertible bond on Oct 13 and its issuance result on Oct 21. Today's headlines do not cite it as a reason for the drop.
How far has it fallen? RSI(14) is 29.1, a short-term oversold zone. The stock sits at the very bottom of its 52-week range, 0%. It is 77.0% below its 52-week high and 59.9% below its 200-day average. On fundamentals it passed 4 of 5 checks, failing only on free cash flow. At the close, 17,045 shares sat on the sell side and there were no buy bids. Volume ran 12.2 times normal. An oversold reading describes position, not a rebound signal.
InBody fell 27% a day after good results, with no filing today

InBody closed at 41,700 won. That is 40.4% below its three-month high and down 10.3% over five days. On Nov 5 it had risen about 22%. One day erased more than that gain.
All filings in the past seven days on DART came out on the morning of Nov 5: preliminary operating results, a treasury-share disposal decision, and a short-selling overheated-stock designation with a trading ban. There is no filing dated Nov 6. No filing we can see gives a direct reason for today's fall.
Press reports describe results that were not bad. Korea Today reported Q3 operating profit up 96.5% and net profit down 53.1%. A Kiwoom Securities report put operating profit 29.5% above expectations. Seoul Economic Daily relayed brokerage analysis that a one-off accounting effect from a stronger won lifted operating profit, and that results roughly met market forecasts even without it. The reports disagree on how strong the quarter was. None of the reports we saw says which of these explains today's drop.
A fact that weighs the other way: a treasury-share disposal decision was filed on Nov 5. Our data has no size or counterparty for it, and we cannot confirm it relates to today's fall.
How far has it fallen? RSI(14) is 36.8, which is not oversold (below 30). The stock sits 34% of the way up its 52-week range. It is 40.6% below its 52-week high and 4.1% below its 200-day average. Fundamental checks were not computed for this stock. Volume ran 10.5 times normal. The closing order book shows 862 shares on the sell side and 545 on the buy side. We have no investor-by-investor flow data, so we do not say who sold.
What to check next. For Seers: whether a filing shows server supply returning to normal, whether Q4 revenue recovers, and any follow-up filings on the 2nd convertible bond. For InBody: the full treasury-share disposal filing for size and counterparty, then trading and investor flows once the short-selling restriction ends.